Source link : https://newshealth.biz/health-news/fitusiran-approved-for-hemophilia-a-b/
The US Food and Drug Administration has approved fitusiran for bleeding prophylaxis in hemophilia A and B with or without inhibitors. Fitusiran is a first-in-class small interfering RNA therapeutic that reduces antithrombin production in the liver by downgrading antithrombin gene expression. Antithrombin is a protein that inhibits clot formation. The agent “has the potential to […]
The post Fitusiran Approved for Hemophilia A, B first appeared on News Health.
Author : News Health
Publish date : 2025-03-28 21:09:00
Copyright for syndicated content belongs to the linked Source.